BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22521551)

  • 1. Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol.
    Barbany G; Andersen MK; Autio K; Borgström G; Franco LC; Golovleva I; Heim S; Heinonen K; Hovland R; Johansson B; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E; ; ;
    Leuk Res; 2012 Jul; 36(7):936-8. PubMed ID: 22521551
    [No Abstract]   [Full Text] [Related]  

  • 2. High incidence of the ETV6/RUNX1 fusion gene in paediatric precursor B-cell acute lymphoblastic leukaemias with trisomy 21 as the sole cytogenetic change: a Nordic series of cases diagnosed 1989-2005.
    Karrman K; Forestier E; Andersen MK; Autio K; Borgström G; Heim S; Heinonen K; Hovland R; Kerndrup G; Johansson B;
    Br J Haematol; 2006 Nov; 135(3):352-4. PubMed ID: 16965388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL.
    Pais AP; Amare Kadam PS; Raje GC; Banavali S; Parikh P; Kurkure P; Arora B; Gujral S; Kumar SA; Badrinath Y
    Pediatr Hematol Oncol; 2008 Sep; 25(6):582-97. PubMed ID: 18728978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Calasanz MJ; Garate L; San Jose-Eneriz E; Cordeu L; Prosper F; Heiniger A; Torres A
    Clin Cancer Res; 2006 Aug; 12(16):4845-50. PubMed ID: 16914570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
    Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Johansson B; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E
    Br J Haematol; 2011 Oct; 155(2):235-43. PubMed ID: 21902680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival.
    Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Rosenquist R; Swolin B; Johansson B; ; ;
    Br J Haematol; 2008 Mar; 140(6):665-72. PubMed ID: 18241254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing chromosomal break points of t(12;21)[ETV6-RUNX1]-positive leukaemia using multiple tiling PCR on whole-genome-amplified DNA.
    Lausten-Thomsen U; Madsen HO; Schmiegelow K
    Leukemia; 2010 Jan; 24(1):203-5. PubMed ID: 19710699
    [No Abstract]   [Full Text] [Related]  

  • 8. Near-tetraploidy in childhood B-cell precursor acute lymphoblastic leukemia is a highly specific feature of ETV6/RUNX1-positive leukemic cases.
    Attarbaschi A; Mann G; König M; Steiner M; Dworzak MN; Gadner H; Haas OA;
    Genes Chromosomes Cancer; 2006 Jun; 45(6):608-11. PubMed ID: 16552772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy.
    Kutlay NY; Pekpak E; Altıner S; Ileri T; Vicdan AN; Dinçaslan H; Ince EU; Tukun FA
    Int J Hematol; 2016 Sep; 104(3):368-77. PubMed ID: 27393278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in ALL (acute lymphoblastic leukemia) cured patients.
    Brassesco MS; Camparoto ML; Tone LG; Sakamoto-Hojo ET
    Cytogenet Genome Res; 2004; 104(1-4):346-51. PubMed ID: 15162063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.
    Stoskus M; Vaitkeviciene G; Eidukaite A; Griskevicius L
    Blood Cells Mol Dis; 2016 Mar; 57():30-4. PubMed ID: 26852652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
    Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K
    Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of der(12)t(12;21)(p13;q22) and as well as additional rearrangements of chromosome 12 homolog in ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Stanchescu R; Betts DR; Rechavi G; Amariglio N; Trakhtenbrot L
    Cancer Genet Cytogenet; 2009 Apr; 190(1):26-32. PubMed ID: 19264230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia in China.
    Gao YJ; Zhu XH; Yang Y; Wu Y; Lu FJ; Zhai XW; Wang HS
    Cancer Genet Cytogenet; 2007 Oct; 178(1):57-60. PubMed ID: 17889709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of ETV6 in intron 2 results in upregulatory and insertional events in childhood acute lymphoblastic leukaemia.
    Jalali GR; An Q; Konn ZJ; Worley H; Wright SL; Harrison CJ; Strefford JC; Martineau M
    Leukemia; 2008 Jan; 22(1):114-23. PubMed ID: 17972957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia.
    Al-Shehhi H; Konn ZJ; Schwab CJ; Erhorn A; Barber KE; Wright SL; Gabriel AS; Harrison CJ; Moorman AV
    Genes Chromosomes Cancer; 2013 Feb; 52(2):202-13. PubMed ID: 23077088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.
    Chen D; Camponeschi A; Nordlund J; Marincevic-Zuniga Y; Abrahamsson J; Lönnerholm G; Fogelstrand L; Mårtensson IL
    Cancer Med; 2021 Jun; 10(12):3997-4003. PubMed ID: 33987955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient with B-cell acute lymphoblastic leukemia with PAX5-ETV6 rearrangement with dic(9;12)(p13;p13) identified by chromosomal microarray.
    Ha J; Kim B; Hahn S; Lee ST; Lyu CJ; Choi JR
    Ann Hematol; 2018 Aug; 97(8):1505-1507. PubMed ID: 29520434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.